BRISBANE, Calif., March 03, 2022 (GLOBE NEWSWIRE) -- Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients ...

Since the early 1990s, the New England-area companies Alexion Pharmaceuticals of Cheshire, Connecticut, and Avant Immunotherapeutics of Needham, Massachusetts, have been linked by their efforts to ...

Stockholm. The complement cascade is a series of consecutively activated proteases that, somewhat like the caspases, culminates in a powerful protein assembly that eventually kills any cell against ...